Erasca Inc Sustainability Reports
Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing medicines for patients with RAS/MAPK pathway-driven cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00MTSR892
5 reports from 2021 to 2025
Company Profile
Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing medicines for patients with RAS/MAPK pathway-driven cancers.
Reports
5 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
